Table 3 Improvement in the mean visual acuity and the mean number of antivascular endothelial growth factor (anti-VEGF) injections 1 year after combined anti-VEGF and laser therapy for patients with diabetic macular oedema.

From: Minimally invasive laser treatment combined with intravitreal injection of anti-vascular endothelial growth factor for diabetic macular oedema

 

Entire study cohort

Patients with initial decimal visual acuities ≤0.5

LogMAR

0.12

0.14

ETDRS

5.9 letters

6.9 letters

Number of injections

3.6

4

  1. logMAR: logarithm of the minimum angle of resolution, ETDRS: Early Treatment of Diabetic Retinopathy Study.